BE-SAFE findings shared at the French geriatrics and gerontology meeting
How can healthcare professionals support safer benzodiazepine deprescribing in older adults? This question was explored by Prof. Anne Spinewine, BE-SAFE coordinator, during the annual meeting of the French Society of Geriatrics and Gerontology (SFGG), held in Paris on 24–26th of November 2025.
Contributing to a session dedicated to deprescribing, Anne presented recent evidence on when and how to deprescribe benzodiazepines, and how to overcome barriers to deprescribing, drawing on findings from BE-SAFE and DI-PRESCRIBE.
The session provided an opportunity to share research insights and discuss practical approaches to improving medication safety for older adults. Bringing these findings into professional exchanges helps connect research with the challenges healthcare teams face in everyday care.
BE-SAFE continues to contribute to this dialogue, supporting a patient-centred approach to reducing benzodiazepine and sedative-hypnotic use among older adults with sleep problems.
BE-SAFE social medias:
BE-SAFE in a nutshell
The BE-SAFE project is targeting patient safety by addressing knowledge and practice gaps related to the reduction of medications used for sleep problems in Europe. Experts and patients are involved to promote an interdisciplinary and inter-sectorial approach. BE-SAFE is a European research project funded by the European Commission Horizon programme under the work programme HORIZON-HLTH-2021-CARE-05-01: Enhancing quality of care and patient safety) and by the Swiss State Secretariat for Education, Research and Innovation (SERI) (contract No 22.00116). The project duration will be from 2022 to 2027.
|
Press contact |
|
|
Prof. Anne Spinewine |
Laura Fernández Maldonado |
|
Project coordinator |
Communication Coordinator |
